Jonathan Charles Alexander Skipper
Direttore/Membro del Consiglio presso Cancer Vaccine Acceleration Co. LLC
Provenienza dei contatti di primo grado di Jonathan Charles Alexander Skipper
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Recepta Biopharma SA
 Recepta Biopharma SA BiotechnologyHealth Technology Recepta Biopharma SA researches and develops drugs for cancer treatment. It is a biotechnology company which is engaged in the research, development, production and marketing of human antibodies for the diagnosis and treatment of human cancer. The company was founded in 2006 and is headquartered in Sao Paulo, Brazil.
11
| Holding Company | Biotechnology | 11 |
| Public Company | Biotechnology | 11 | |
iTeos Therapeutics SA
 iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
Ludwig Institute for Cancer Research Ltd.
 Ludwig Institute for Cancer Research Ltd. Medical/Nursing ServicesHealth Services Ludwig Institute For Cancer Research Ltd. is non-profit organization engages in the prevention and control of cancer through researches, integrated laboratory and clinical trials. The firm operates in the areas of cell biology, genomics, immunology, neuroscience, signaling, stem cells, therapeutic, tumor biology, brain and breast cancer, immunotherapy, and melanoma. The company was founded by Daniel K. Ludwig in 1971 and is headquartered in New York, NY.
10
| Non-Profit Organization | Medical/Nursing Services | 10 |
iOX Therapeutics Ltd.
 iOX Therapeutics Ltd. BiotechnologyHealth Technology iOX Therapeutics Ltd. provides cancer therapeutics services. The company was founded by Vincenzo Cerundolo in February 2015 and is headquartered in London, the United Kingdom.
2
| Private Company | Biotechnology | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jonathan Charles Alexander Skipper tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Director/Board Member | |
| PROCTER & GAMBLE COMPANY | Household/Personal Care | Corporate Officer/Principal | |
| PORTAGE BIOTECH INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
HBM Partners AG
 HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US. | Investment Managers | Private Equity Investor | |
| THE SUSTAINABLE NUTRITION GROUP LTD | Agricultural Commodities/Milling | Director/Board Member Director/Board Member | |
Cancer Council Victoria
 Cancer Council Victoria Miscellaneous Commercial ServicesCommercial Services Cancer Council Victoria operates as a not-for-profit organisation specializing in cancer control. It provides support, prevention, research, and health professional services. The company was founded in 1936 and is headquartered in Melbourne, Austalia. | Miscellaneous Commercial Services | Director of Finance/CFO | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Masters Business Admin | |
| Stanford University | College/University | Undergraduate Degree | |
Monash University
 Monash University Other Consumer ServicesConsumer Services Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia. | College/University | Doctorate Degree Doctorate Degree | |
| The University of Southampton | College/University | Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Doctorate Degree | |
| The University of Sydney | College/University | Undergraduate Degree | |
| ABLYNX | Biotechnology | Corporate Officer/Principal | |
| Queensland University of Technology | College/University | Doctorate Degree | |
| University of Zurich | College/University | Doctorate Degree | |
| University of Pavia | College/University | Undergraduate Degree | |
| Ghent University | College/University | Graduate Degree | |
| Deakin University | College/University | Undergraduate Degree | |
Ogeda SA
 Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| Vlerick Leuven Gent Management School | College/University | Masters Business Admin | |
Vegenics Pty Ltd.
 Vegenics Pty Ltd. Medical/Nursing ServicesHealth Services Part of Opthea Ltd., Vegenics Pty Ltd. is an Australian company that provides medical research, development, and commercialization of biologic drugs. Vegenics was acquired by Opthea Ltd. on August 14, 2008 for $5.06 million. | Medical/Nursing Services | Corporate Secretary | |
| Université Catholique de Louvain | College/University | Doctorate Degree | |
| Agen Biomedical Ltd. | Corporate Officer/Principal | ||
| BIOATLA, INC. | Biotechnology | Director/Board Member | |
| ARGENX SE | Pharmaceuticals: Other | Founder | |
| SECOS GROUP LIMITED | Environmental Services | Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
Neurelis, Inc.
 Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
i3 Global
 i3 Global Miscellaneous Commercial ServicesCommercial Services i3 Global operates as a pharmaceutical services company. It offers therapeutically specialized contract research solutions, clinical data services, staffing solutions, pharmacovigilance and epidemiology solutions. The company was founded in 1988 and is headquartered in Bernards, NJ. | Miscellaneous Commercial Services | Director/Board Member | |
Medicines Development for Global Health Ltd
 Medicines Development for Global Health Ltd Pharmaceuticals: MajorHealth Technology Medicines Development Ltd. engages in the development of medicines and vaccines. Its development programs include Moxidectin Program, Global Health Programs, and Consulting ervices. The company was founded by Mark Sullivan in 2005 and is headquartered in Melbourne, Australia. | Pharmaceuticals: Major | Founder | |
HBM Healthcare Investments (Cayman) Ltd.
 HBM Healthcare Investments (Cayman) Ltd. Hospital/Nursing ManagementHealth Services Part of HBM Partners AG, HBM Healthcare Investments (Cayman) Ltd. provides healthcare services. The company is based in George Town, Cayman Islands. Andreas Wicki has been the CEO of the company since 2001. | Hospital/Nursing Management | Director/Board Member | |
Q-Gen Pty Ltd.
 Q-Gen Pty Ltd. Pharmaceuticals: MajorHealth Technology Q-Gen Pty Ltd. is an Australian company. | Pharmaceuticals: Major | Chief Operating Officer | |
| Faculdade de Direito da Universidade de São Paulo | College/University | Undergraduate Degree | |
| SALVARX GROUP PLC | Biotechnology | Founder Founder | |
Aelin Therapeutics NV
 Aelin Therapeutics NV Pharmaceuticals: MajorHealth Technology Aelin Therapeutics NV develops drugs for antibiotics and first-in-class therapeutics. The company is based in Leuven, Belgium. The Belgian company was founded in 2017. The CEO is Els Beirnaert. | Pharmaceuticals: Major | Chairman | |
Ona Therapeutics SL
 Ona Therapeutics SL Pharmaceuticals: MajorHealth Technology Ona Therapeutics SL is a biotech company based in Barcelona, Spain that specializes in discovering and developing therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. The Spanish company's focus is on developing novel therapies against advanced cancer. The company was founded in 2019 by Salvador Aznar Benitah and Valerie Liesbeth Brigitte Vanhooren, with Valerie Liesbeth Brigitte Vanhooren serving as CEO since incorporation. | Pharmaceuticals: Major | Chairman | |
Adjuvant Capital LP
 Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
| University of New South Wales Built Environment | College/University | Chief Operating Officer | |
| ITEOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman Chief Operating Officer Director/Board Member Director/Board Member Founder | |
| RAYZEBIO, INC. | Biotechnology | Director/Board Member | |
Innoskel SASU
 Innoskel SASU BiotechnologyHealth Technology Innoskel SASU is a French bioscience platform company that aims to improve the quality of life of patients with severe rare bone disorders. Innoskel is based in Valbonne, France, and was founded by Elvire Gouze, who has been the CEO since incorporation. The company achieves this goal through patient centricity, scientific innovation, and operational excellence. Innoskel is developing transformative therapies for the unmet needs of individuals with rare bone disorders, with a focus on type II collagen disorders. The company's lead asset is INS-101, a gene therapy that has shown strong efficacy in preclinical studies. | Biotechnology | Chairman | |
| Global Health Funds LLC | Consultant / Advisor | ||
| IO BIOTECH, INC. | Biotechnology | Director/Board Member | |
Mahzi Therapeutics, Inc.
 Mahzi Therapeutics, Inc. BiotechnologyHealth Technology Mahzi Therapeutics is a private biotechnology company that focuses on genetic therapies for rare genetic neurodevelopmental disorders. The company was founded by Yael Weiss and is based in San Mateo, CA. The company unites patient and family groups, academic researchers, diagnostic companies, other industry members, and its internal team of experts to develop therapies for patients with these serious diseases. Mahzi's team is experienced in all aspects of biopharmaceutical research, development, and manufacturing and is driven to make a difference in the lives of patients with rare genetic diseases. Yael Weiss has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Iteos Belgium SA
 Iteos Belgium SA Pharmaceuticals: MajorHealth Technology Iteos Belgium SA manufactures pharmaceutical raw materials. The private company is based in Gosselies, Belgium. | Pharmaceuticals: Major | Chief Executive Officer | |
| Ludwig Cancer Research | Director/Board Member | ||
AdrenoMed AG
 AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 18 |
| Australia | 14 |
| Belgio | 8 |
| Svizzera | 3 |
| Regno Unito | 3 |
Settori
| Health Technology | 22 |
| Consumer Services | 16 |
| Finance | 4 |
| Commercial Services | 3 |
| Health Services | 3 |
Posizioni
| Director/Board Member | 88 |
| Corporate Officer/Principal | 40 |
| Independent Dir/Board Member | 24 |
| Chairman | 22 |
| Chief Executive Officer | 17 |
Contatti più connessi
| Insiders | |
|---|---|
| Ann Rhoads | 19 |
| David Hallal | 15 |
| Ian Walters | 15 |
| Carlo Montagner | 13 |
| John Wilcox Stocker | 12 |
| Christiana Goh Bardon | 10 |
| Priyanka Belawat | 10 |
| Matthew Call | 9 |
| Tim van Hauwermeiren | 9 |
| Robert Kramer | 8 |
| Errol Malta | 8 |
| Michel Detheux | 8 |
| Mark Sullivan | 8 |
| Nancy E. Davidson | 7 |
| Michael Gerometta | 6 |
- Borsa valori
- Insiders
- Jonathan Charles Alexander Skipper
- Connessioni Società
